0000874716-24-000037.txt : 20240216
0000874716-24-000037.hdr.sgml : 20240216
20240216175606
ACCESSION NUMBER: 0000874716-24-000037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240214
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnson Michael Perkins
CENTRAL INDEX KEY: 0001917747
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 24649855
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
STREET 2: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
wk-form4_1708124148.xml
FORM 4
X0508
4
2024-02-14
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001917747
Johnson Michael Perkins
ONE IDEXX DRIVE
WESTBROOK
ME
04092
0
1
0
0
EVP and CHRO
0
Common Stock
2024-02-14
4
M
0
176
0
A
243.3419
D
Common Stock
2024-02-14
4
F
0
60
560.56
D
183.3419
D
Non-Qualified Stock Option (right-to-buy)
560.56
2024-02-14
4
A
0
3132
0
A
2034-02-13
Common Stock
3132
3132
D
Incentive Stock Option (right-to-buy)
560.56
2024-02-14
4
A
0
178
0
A
2034-02-13
Common Stock
178
178
D
Restricted Stock Unit
0
2024-02-14
4
A
0
714
0
A
Common Stock
714
714
D
Restricted Stock Unit
2024-02-14
4
M
0
176
0
D
Common Stock
176
528
D
Includes a total of 51.542 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2023, June 30, 2023, September 29, 2023 and December 29, 2023.
Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025.
Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028.
Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024.
/s/ Lily J. Lu, Attorney-in-Fact for Michael P. Johnson
2024-02-16